Effects of Switching from Insulin Glargine or Detemir to Insulin Degludec in Patients with Type 1 Diabetes Mellitus

被引：0
|
作者：
Yoshiki Kusunoki
Tomoyuki Katsuno
Kana Miyakoshi
Takashi Ikawa
Rie Nakae
Fumihiro Ochi
Masaru Tokuda
Takafumi Akagami
Kazuki Murai
Masayuki Miuchi
Tomoya Hamaguchi
Jun-ichiro Miyagawa
Mitsuyoshi Namba
机构：
[1] Hyogo College of Medicine,Division of Diabetes, Endocrinology, and Metabolism, Department of Internal Medicine
[2] Hyogo College of Medicine,Innovative Diabetes Treatment
来源：
Diabetes Therapy | 2013年 / 4卷
关键词：
Basal–bolus insulin therapy; Continuous glucose monitoring; Hypoglycemia; Type 1 diabetes mellitus; Insulin degludec; Insulin glargine or detemir;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：461 / 472
页数：11
相关论文
共 50 条
  • [21] A randomized crossover study of the efficacy and safety of switching from insulin glargine to insulin degludec in children with type 1 diabetes
    Urakami, Tatsuhiko
    Mine, Yusuke
    Aoki, Masako
    Okuno, Misako
    Suzuki, Junichi
    [J]. ENDOCRINE JOURNAL, 2017, 64 (02) : 133 - 140
  • [22] Effects of Insulin Detemir Versus Insulin Glargine on Intake and Satiety Factors in Type 1 Diabetes
    Garimella, Madhavi
    Mitchell, Stephen
    Burge, Mark R.
    [J]. DIABETES, 2011, 60 : A687 - A687
  • [23] Comparison of Insulin Detemir and Insulin Glargine on Glycemic Variability in Patients with Type 1 and Type 2 Diabetes
    Tone, A.
    Iseda, I.
    Higuchi, C.
    Tsukamoto, K.
    Katayama, A.
    Matsushita, Y.
    Hida, K.
    Wada, J.
    Shikata, K.
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2010, 118 (05) : 320 - 324
  • [24] EFFICACY AND SAFETY OF SWITCHING FROM INSULIN DETEMIR TO INSULIN DEGLUDEC WITH MEALTIME INSULIN ASPART IN PEDIATRIC PATIENTS WITH TYPE 1 DIABETES. AN OBSERVATIONAL PROSPECTIVE STUDY
    Elbarbary, Nancy S.
    [J]. HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 : 45 - 45
  • [25] Real World Outcomes of Switching from Insulin Glargine (GLA) to Insulin Detemir (DET) in Medicaid Patients With Type 2 Diabetes
    Cao, Zhun
    Wei, Wenhui
    Miao, Raymond
    Thomson, Erin
    [J]. DIABETES, 2013, 62 : A648 - A648
  • [26] Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Adults with Type 1 and Type 2 Diabetes Mellitus
    Marc Evans
    Barrie Chubb
    Jens Gundgaard
    [J]. Diabetes Therapy, 2017, 8 : 275 - 291
  • [27] Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Adults with Type 1 and Type 2 Diabetes Mellitus
    Evans, Marc
    Chubb, Barrie
    Gundgaard, Jens
    [J]. DIABETES THERAPY, 2017, 8 (02) : 275 - 291
  • [28] Effects of Switching from Degludec to Glargine U300 in Patients with Insulin-Dependent Type 1 Diabetes: A Retrospective Study
    Sawamura, Toshitaka
    Karashima, Shigehiro
    Ohbatake, Azusa
    Higashitani, Takuya
    Ohmori, Ai
    Sawada, Kei
    Yamamoto, Rika
    Kometani, Mitsuhiro
    Katsuda, Yuko
    Yoneda, Takashi
    [J]. MEDICINA-LITHUANIA, 2024, 60 (03):
  • [29] Intensified insulin therapy of type 2 diabetes mellitus: Insulin glargine vs. insulin detemir as basal insulin
    Jungmann, Eckart
    [J]. DIABETES, 2006, 55 : A118 - A118
  • [30] Higher insulin detemir doses are required for the similar glycemic control: comparison of insulin detemir and glargine in children with type 1 diabetes mellitus
    Abali, Saygin
    Turan, Serap
    Atay, Zeynep
    Guran, Tulay
    Haliloglu, Belma
    Bereket, Abdullah
    [J]. PEDIATRIC DIABETES, 2015, 16 (05) : 361 - 366
12345